Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Neoplastic Cells, Circulating
×
Standard of Care
×
Clear all
Filters
2
NCT06391892
2024-04-30
LIQUIPANC
Elisabethinen Hospital
Phase 3
Recruiting
100 enrolled
NCT01129336
2014-05-20
MACS1295
Novartis
Phase 4
Completed
44 enrolled
10 charts